v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Class A and Class B Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2025     255,443,000        
Beginning balance at Jan. 31, 2025 $ 612,063   $ 8 $ 966,454 $ (23,831) $ (6,969) $ (323,599)
Beginning balance (in shares) at Jan. 31, 2025         14,131,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation - equity classified awards 43,805     43,805      
Exercise of stock options and release of vested restricted stock units (in shares)     5,742,000        
Exercise of stock options and release of vested restricted stock units 12,939     12,939      
Issuance of common shares upon ESPP purchases (in shares)     412,000        
Issuance of common shares upon ESPP purchases 2,785     2,785      
Common stock repurchased, including accrued excise tax (in shares)     (16,495,000)        
Common stock repurchased, including accrued excise tax (141,429) $ (1)   (141,428)      
Other comprehensive (loss) income 2,227         2,227  
Net income (loss) 11,047           11,047
Ending balance (in shares) at Jul. 31, 2025     245,102,000        
Ending balance at Jul. 31, 2025 543,437   $ 7 884,555 $ (23,831) (4,742) (312,552)
Ending balance (in shares) at Jul. 31, 2025         14,131,000    
Beginning balance (in shares) at Apr. 30, 2025     257,899,000        
Beginning balance at Apr. 30, 2025 639,772   $ 8 991,414 $ (23,831) (2,652) (325,167)
Beginning balance (in shares) at Apr. 30, 2025         14,131,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation - equity classified awards 21,692     21,692      
Exercise of stock options and release of vested restricted stock units (in shares)     3,286,000        
Exercise of stock options and release of vested restricted stock units 10,092     10,092      
Issuance of common shares upon ESPP purchases (in shares)     412,000        
Issuance of common shares upon ESPP purchases 2,785     2,785      
Common stock repurchased, including accrued excise tax (in shares)     (16,495,000)        
Common stock repurchased, including accrued excise tax (141,429) $ (1)   (141,428)      
Other comprehensive (loss) income (2,090)         (2,090)  
Net income (loss) 12,615           12,615
Ending balance (in shares) at Jul. 31, 2025     245,102,000        
Ending balance at Jul. 31, 2025 543,437   $ 7 884,555 $ (23,831) (4,742) (312,552)
Ending balance (in shares) at Jul. 31, 2025         14,131,000    
Beginning balance (in shares) at Jan. 31, 2026     248,724,000        
Beginning balance at Jan. 31, 2026 $ 592,643   $ 7 922,872 $ (23,831) (5,711) (300,694)
Beginning balance (in shares) at Jan. 31, 2026 14,130,784       14,131,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation - equity classified awards $ 41,917     41,917      
Exercise of stock options and release of vested restricted stock units (in shares)     4,982,000        
Exercise of stock options and release of vested restricted stock units 1,269     1,269      
Issuance of common shares upon ESPP purchases (in shares)     469,000        
Issuance of common shares upon ESPP purchases 2,121     2,121      
Common stock repurchased, including accrued excise tax (in shares)     (17,123,000)        
Common stock repurchased, including accrued excise tax (125,723)     (125,723)      
Other comprehensive (loss) income (4,049)         (4,049)  
Cancellation of treasury stock 0     (23,831) $ 23,831    
Cancellation of treasury stock (in shares)         (14,131,000)    
Net income (loss) 11,299           11,299
Ending balance (in shares) at Jul. 31, 2026     237,052,000        
Ending balance at Jul. 31, 2026 $ 519,477   $ 7 818,625 $ 0 (9,760) (289,395)
Ending balance (in shares) at Jul. 31, 2026 0       0    
Beginning balance (in shares) at Apr. 30, 2026     233,984,000        
Beginning balance at Apr. 30, 2026 $ 488,460   $ 7 794,015 $ 0 (9,049) (296,513)
Beginning balance (in shares) at Apr. 30, 2026         0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation - equity classified awards 21,210     21,210      
Exercise of stock options and release of vested restricted stock units (in shares)     2,599,000        
Exercise of stock options and release of vested restricted stock units 1,139     1,139      
Issuance of common shares upon ESPP purchases (in shares)     469,000        
Issuance of common shares upon ESPP purchases 2,121     2,121      
Common stock repurchased, including accrued excise tax 140     140      
Other comprehensive (loss) income (711)         (711)  
Net income (loss) 7,118           7,118
Ending balance (in shares) at Jul. 31, 2026     237,052,000        
Ending balance at Jul. 31, 2026 $ 519,477   $ 7 $ 818,625 $ 0 $ (9,760) $ (289,395)
Ending balance (in shares) at Jul. 31, 2026 0       0